From e922e12b9e1ce5de1ee628dc1c239dc10734ab91 Mon Sep 17 00:00:00 2001
From: Anna Baack <anna-lena.baack@uni-bielefeld.de>
Date: Fri, 27 Sep 2024 15:58:31 +0000
Subject: [PATCH] Update file Feedback.tsx
---
src/contents/Human Practices/Feedback.tsx | 5 +++++
1 file changed, 5 insertions(+)
diff --git a/src/contents/Human Practices/Feedback.tsx b/src/contents/Human Practices/Feedback.tsx
index 5dc9f314..b609420a 100644
--- a/src/contents/Human Practices/Feedback.tsx
+++ b/src/contents/Human Practices/Feedback.tsx
@@ -13,8 +13,13 @@ export function HPFeedback(){
<div className="row align-items-center">
<div className="col">
<HowOftenTreatmentatients/>
+ <p>The majority of respondents (62.70%) indicated that they or their relative require medical treatment or therapy daily. Weekly treatment was necessary for 14.59%, while 9.73% needed therapy several times per week. Only 6.49% reported needing treatment either monthly or rarely. The high frequency of daily treatments highlights the heavy burden of managing cystic fibrosis and reinforces the potential appeal of gene therapy, which could reduce the need for constant medical intervention. </p>
<OpenToGeneTherapyatients/>
+ <p>A significant majority, 78.72%, indicated that they would be open to gene therapy if it significantly improved symptoms, while only 1.42% said no. This overwhelming support aligns with the hope patients have for less invasive and more effective treatments. This also reflects the possibility of gene therapy becoming a central treatment method, especially given the heavy therapeutic load CF patients already carry.</p>
<MoreInfoOnTherapyBoth/>
+ <p>A vast majority, 93.48%, expressed interest in more information about gene therapy. This mirrors the general public’s desire for further education and suggests that while there is strong support for gene therapy, people still feel they lack sufficient knowledge to make fully informed decisions. Patients especially emphasized the importance of safety and long-term efficacy, areas that should be focal points in future communications. </p>
+
+
</div>
</div>
</div>
--
GitLab